Lumampi, Hurry P.
HRN: 28-71-38 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/20/2026
03/27/2026
IV
500mg
Q8H
Amoebiasis
Checking Initial Appropriateness